BioNTech drops indications, stops making cell therapy at Maryland sitenews2025-06-18T15:25:03+00:00June 18th, 2025|Endpoints News|
Capricor gets Form 483 from FDA; WuXi Biologics’ new China factory news2025-06-12T14:00:36+00:00June 12th, 2025|Endpoints News|
National Resilience to shutter six manufacturing sites amid biotech slowdownnews2025-06-09T20:12:12+00:00June 9th, 2025|Endpoints News|
Twist Bioscience urges Trump administration for tariffs on synthetic DNAnews2025-06-09T17:58:58+00:00June 9th, 2025|Endpoints News|
Sanofi speeds up global shipping for Beyfortus as RSV antibody market set to heat upnews2025-06-09T10:48:43+00:00June 9th, 2025|Endpoints News|
US pharma imports normalize after March tariff stockpilingnews2025-06-06T13:23:24+00:00June 6th, 2025|Endpoints News|
Schott Pharma’s €100M+ Hungary expansion; Antheia’s $56M Series C raisenews2025-06-05T15:32:51+00:00June 5th, 2025|Endpoints News|
Agenus to divest CDMO business to Zydus for $75M upfrontnews2025-06-03T15:27:08+00:00June 3rd, 2025|Endpoints News|
Q&A: Sandoz CEO talks generic GLP-1s, Trump’s tariffs, Mark Cuban’s companynews2025-06-03T11:00:52+00:00June 3rd, 2025|Endpoints News|
Big pharma companies explain why tariffs will harm US investments news2025-05-29T16:27:27+00:00May 29th, 2025|Endpoints News|
